$CERT 3 SEC Filings

Filed On	Filing
17 Jul 2026	Form 3: Mohammed Faiz, Interim CFO Holds 163,686 shares of Common Stock
02 Mar 2026	Form 3: Bedi Arjun, Director No securities owned
12 Jan 2026	Form 3: Resnick Jon Matthew, Director No securities owned
10 Mar 2025	Form 3: McKemey Adrian, President, Drug Dev. Solutions No securities owned
18 Oct 2024	Form 3: Reynders John V W, Director No securities owned
30 May 2024	Form 3: Anhalt Rona, Chief Human Resources Officer No securities owned
30 May 2024	Form 3: Corcoran Daniel, SVP and General Counsel No securities owned
03 Apr 2023	Form 3: Gallagher John E, CHIEF FINANCIAL OFFICER No securities owned
16 Dec 2022	Form 3: Arsenal Capital Investment Vi Lp, 10% owner and 6 others Holds 36,345,835 shares of Common stock, $0.01 par value
08 Dec 2022	Form 3: Spaight David, Director No securities owned
09 Sep 2022	Form 3: Virkler Drayton, Interim President, Reg & Acces
22 Jul 2022	Form 3: Crane Rosemary A, Director No securities owned
15 Jul 2022	Form 3: Broshy Eran, Director No securities owned
01 Nov 2021	Form 3: Smith Patrick F, PRESIDENT, INTEGRATED DRUG DEV Holds 99,743 shares of Common Stock
02 Aug 2021	Form 3: Collins Cynthia, Director No securities owned
02 Aug 2021	Form 3: Killefer Nancy, Director No securities owned
16 Jul 2021	Form 3: Sherman Nicolette D, Chief Human Resources Officer No securities owned
16 Jun 2021	Form 3: Gallagher Carol Giltner, Director No securities owned
11 Dec 2020	Form 3: Choe Jieun W., See Remarks Holds 324,676 shares of Common Stock
11 Dec 2020	Form 3: Traynor Richard M., See Remarks Holds 341,558 shares of Common Stock

Comments